Articles From: Molson Coors CEO Peter Swinburn to Retire at End of 2014; Board Names Molson Coors Europe CEO Mark Hunter as Successor to MONDAY DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Blucora, Inc. and a Lead Plaintiff Deadline of July 14, 2014 -- BCOR


2014/7/25
Molson Coors Brewing Company (NYSE: TAP; TSX: TPX) today announced that after a 40-year career in the beer business, Peter S.
Sign-up for Molson Coors CEO Peter Swinburn to Retire at End of 2014; Board Names Molson Coors Europe CEO Mark Hunter as Successor investment picks
Molson Coors Brewing Company (NYSE: TAP) has maintained its listing on the World Index for the third consecutive year and North America Index for the fourth consecutive year.
Sign-up for Molson Coors Named to Dow Jones Sustainability Index for Third Consecutive Year investment picks
2014/10/7
Molson Coors Brewing Company (NYSE: TAP; TSX: TPX) today announced that Frederic Landtmeters, Chief Commercial Officer, Molson Coors Europe, will take over as Managing Director, Molson Coors UK and Ireland, succeeding Simon Cox who will take on the role of CEO Molson Coors Europe from January 1 st 2015.
Sign-up for Molson Coors Names Frederic Landtmeters Managing Director of UK & Ireland investment picks
2014/8/29
Molson Coors Brewing Company (NYSE: TAP; TSX: TPX) today announced that Simon Cox, 46, Managing Director of Molson Coors - UK and Ireland, will take over as CEO Europe succeeding Mark Hunter, who will take the top job at Molson Coors Brewing Company when current President and CEO Peter Swinburn retires at the end of the year.
Sign-up for Molson Coors Names Simon Cox CEO Europe investment picks
2014/8/6
NEW YORK (MarketWatch) -- Molson Coors Brewing Company (TAP.NV.T) said it earned $290.7 million, or $1.56 a share, in the second quarter, up from $267.3 million, or $1.44 a share, in the year-earlier period, buoyed by its MillerCoors and Europe businesses.
Sign-up for Molson Coors profit, sales top estimates investment picks
Molson Coors Brewing Company (NYSE: TAP) today announced the online publication of its 2014 Our Beer Print Corporate Responsibility Report, covering the company’s performance in five key areas: Government and Ethics, Alcohol Responsibility, Environmental Stewardship, Employees and Community and Responsible Sourcing.
Sign-up for Molson Coors Releases 2014 Corporate Responsibility Report investment picks
2014/8/6
Molson Coors Brewing Company (NYSE: TAP; TSX: TPX) today reported a 7.9 percent increase in underlying after-tax income for the second quarter 2014, driven by improved performance from MillerCoors and Europe, along with lower interest expense versus a year ago.
Sign-up for Molson Coors Reports Higher Sales, Underlying After-Tax Income and EBITDA for the Second Quarter 2014 investment picks
CAMBRIDGE, Mass., July 15, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) , a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the second quarter ended June 30, 2014 before the U.S. financial markets open on Thursday, July 31, 2014.
Sign-up for Momenta Pharmaceuticals Announces Date of Second Quarter 2014 Financial Results Conference Call and Webcast investment picks
CAMBRIDGE, Mass., Sept.
Sign-up for Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibodies From AnaptysBio investment picks
SHM-XEL Platform Successfully Generates Novel Therapeutic Approach to Autoimmune Disease SAN DIEGO , Sept.
Sign-up for Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibody Program from AnaptysBio investment picks
CAMBRIDGE, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the second quarter ended June 30, 2014.
Sign-up for Momenta Pharmaceuticals Reports Second Quarter 2014 Financial Results investment picks
CAMBRIDGE, Mass., Oct.
Sign-up for Momenta Pharmaceuticals to Host 2014 R&D Day investment picks
CAMBRIDGE, Mass., July 30, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that its presentation at the Canaccord Genuity Growth Conference will be webcast on Thursday, August 14 at 4:00 p.m. ET.
Sign-up for Momenta Pharmaceuticals to Webcast Presentation at the Canaccord Genuity Growth Conference investment picks
2014/9/1
ARM ® is celebrating the signing of the 50 th licensing agreement for its ARMv8-A technology, which includes support for 64-bit computing.
Sign-up for Momentum Builds for the Next Generation of ARM Processors investment picks
2014/10/15
ADVISORY, Oct.
Sign-up for Momentum Events, The Pivot Conference, to Ring The Nasdaq Stock Market Closing Bell investment picks
2014/8/28
Wilberforce University Looks to the Future, Announces Prominent Entrepreneur and Denny's CEO as New Board Leadership WILBERFORCE, Ohio , Aug.
Sign-up for Momentum Gaining At Nation's Oldest HBCU investment picks
2014/10/15
More than 6,000 Customers Will Benefit from Project, Including Snowshoe Mountain Resort Area FAIRMONT, W.Va. , Oct.
Sign-up for Mon Power Installs New Equipment to Enhance Service Reliability in Pocahontas County, W.Va. investment picks
CHESAPEAKE, Va., Aug.
Sign-up for Monarch Bank Announces Banking Footprint Enhancements investment picks
CHESAPEAKE, Va., Aug.
Sign-up for Monarch Bank Hires Andy Proctor to Lead New Richmond Loan Production Office investment picks
RENO, Nev., July 24, 2014 (GLOBE NEWSWIRE) -- Monarch Casino & Resort, Inc. (Nasdaq:MCRI) ("Monarch" or "the Company") today reported operating results for the quarter and six months ended June 30, 2014, as summarized below: CEO Comment John Farahi, Co-Chairman and Chief Executive Officer of Monarch, commented, "We are disappointed with our second quarter results as operations were impacted by higher operating expenses and lower revenue at both Atlantis and Monarch Black Hawk.
Sign-up for Monarch Casino & Resort Reports Second Quarter Net Revenue of $47.8 Million and Adjusted EBITDA of $11.7 Million investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153406&ProfileId=051205&sourceType=1 RENO, NV --
Sign-up for Monarch Casino & Resort, Inc. Reports Third Quarter Net Revenue of $48.6 Million and Adjusted EBITDA of $12.0 Million investment picks
http://media.marketwire.com/attachments/201310/67520_monarch.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1138313&ProfileId=051205&sourceType=1 BLACK HAWK, CO --
Sign-up for Monarch Casino Black Hawk Completes First Phase Redesign investment picks
CHESAPEAKE, Va., July 24, 2014 (GLOBE NEWSWIRE) -- Monarch Financial Holdings, Inc. (Nasdaq:MNRK) , the bank holding company for Monarch Bank, reported second quarter profitability and continued strong financial performance.
Sign-up for Monarch Financial Reports Financial Performance and Declares Cash Dividend investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0960863001&sourceType=1 PARRAL, MEXICO --
Sign-up for Monarchy Resources Provides Operational Update investment picks
2014/7/25
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Vertex Pharmaceuticals Incorporated (“Vertex” or the “Company”) (NasdaqGS:VRTX) securities between May 7, 2012 and May 29, 2012.
Sign-up for MONDAY DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX investment picks
NEW YORK, July 11, 2014 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Western District of Washington on behalf of investors who purchased Blucora, Inc. ("Blucora" or the "Company") (Nasdaq:BCOR) common stock between November 5, 2013 and February 20, 2014.
Sign-up for MONDAY DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Blucora, Inc. and a Lead Plaintiff Deadline of July 14, 2014 -- BCOR investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Molson Coors CEO Peter Swinburn to Retire at End of 2014; Board Names Molson Coors Europe CEO Mark Hunter as Successor to MONDAY DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Blucora, Inc. and a Lead Plaintiff Deadline of July 14, 2014 -- BCOR
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices